Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Other Operating Expenses (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Other Operating Expenses for 2 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 31.36% to $9.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Dec 2025, down 97.85% year-over-year, with the annual reading at $9.3 million for FY2025, 97.85% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $9.3 million at Nuvation Bio, up from $7.1 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $425.1 million in Q2 2024, with the low at $7.1 million in Q4 2024.